Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
7.74
USD
-1.65%
Market Closed
Market Cap:
$601.8m
Relative Value
The Relative Value of one
CDXC
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 7.74 USD,
Chromadex Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CDXC Relative Value
HIDDEN
Multiples Across Competitors
CDXC Competitors Multiples
Chromadex Corp Competitors
Chromadex Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Chromadex Corp
NASDAQ:CDXC
|
598.5m USD | 6 | 70 | 64.9 | 71.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 367.7 | 4 354.1 | 1 380.5 | 2 949.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
191B USD | 4.3 | 28.5 | 19.9 | 26.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
145.7B USD | 5.9 | 40.3 | 20.4 | 29.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 15 | 51.6 | 30.3 | 40.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.4B CHF | 5.6 | 38.4 | 28.4 | 28.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
272.8B CNY | 6.1 | 18.2 | 18.3 | 18.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.5B USD | 4.7 | 25.9 | 20.3 | 24.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.8B USD | 1.8 | 21.5 | 12 | 17.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.1B USD | 6.7 | 31.1 | 23 | 25.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
17.5B EUR | 5.9 | 65.8 | 22.2 | 35.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
